China Sunsine Chemicals Holdings

[CityFarmer]

The ASP of individual product is obtained from the the table "analysis of sales and volume" in page 9 of the results announcement.
My comparison is between 3Q and 2Q. While the reported 2Q 2012 profit was RMB 11.2m, actual should have been RMB 20.5m if not for the RMB 9.3m on 6PPD trial run in that quarter.

ASP of anti-oxidants ought to be much higher as the open market price of 6PPD used to be twice that of TMQ. It was very likely that 6PPD was sold at a loss in 3Q as production volume was small.

I did not comment on the performance of accelerators in my earlier post because the ASP dipped slightly from RMB 18,900 in 2Q to RMB 18,400 in 3Q on comparable volume of around 16,600 tonnes. You are right in saying that accelerators, the main revenue contributor, could have been the lead culprit of the profit decline. The small price dip of RMB 500 for a tonne of accelerators resulted in a considerable loss of RMB 8.3m for the sales volume.

I wonder how do you derive gross profit by products in previous posting?